Clinical Trial Update: Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

The completed Phase 2 trial reports on the efficacy and safety of LEP-ETU for metastatic breast cancer, sponsored by INSYS Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LEP-ETU (liposome-entrapped paclitaxel)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED